MICROCHIP TECHNOLOGY INCORPORATED
At today's price, MICROCHIP TECHNOLOGY INCORPORATED (MCHP) is priced for today's economics sustained for ~16.7 years. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
Microchip is a moat-rich embedded-control franchise coming out of a deep cyclical trough. Gross margin has recovered to 61.6% from a 52% bottom, and management declared the inventory correction complete with the largest booking month in nearly four years. The price prices the recovery aggressively. At $99.71 (as of June 27, 2026) no valuation family reaches the price, and the embedded margin assumption is far above what the company earns today, so the buyer is paying for a full normalization.
Is MCHP overvalued? See what's priced in →
1,124 institutional managers reported holding MCHP in 13F filings for the quarter ended 2026-03-31. Together they hold about 92% of the company; the top 10 hold 45%. 128 opened new positions that quarter. Held by Vanguard Group, BlackRock, State Street, among others. On the short side, 40.9M shares were sold short as of the 2026-06-15 count, about 8% of shares outstanding (3.3 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
MCHP has cut its share count 1.2% over the past five years, spending $2.46B on repurchases. It pays a dividend, and has paid one every year in our records (18 and counting); the current rate is $1.82 a share annually. Cash returned over the past three years: $2.66B in dividends and $944.20M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at MCHP over the trailing three years. Absence is a fact about the company, not a signal. 14 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
MCHP's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-04 | -7.5% | -4.7% |
| 2023-11-03 | +7.6% | +9.9% |
| 2024-02-02 | -1.0% | +3.9% |
| 2024-05-24 | +0.8% | -11.6% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
MCHP's latest 8-K filings: 2026-06-01 (items 5.02); 2026-05-07 (items 2.02, 9.01); 2026-02-11 (items 1.01, 2.03, 3.02, 8.01, 9.01); 2026-02-05 (items 2.02, 9.01); 2026-01-05 (items 2.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: July 3, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.